# ë°°ê²½ ìë£Œ: S3 ë‹¨ë°±ì§ˆ ë° ë§‰ í•­ìƒì„± ì „ëµ

**ì„¸ì…˜**: S3 - Cellular Strategies for Protein and Membrane Homeostasis
**ì¼ì‹œ**: 2025ë…„ 10ì›” 27ì¼ (ì›”) 09:00-11:00
**ì¥ì†Œ**: Convention Hall 1
**ì¤‘ìš”ë„**: â­ (70/100ì )
**Co-organized by**: Kangwon National University G-LAMP Center

---

## ğŸ¯ ì„¸ì…˜ ê°œìš”

ì´ ì„¸ì…˜ì€ **ë‹¨ë°±ì§ˆ í’ˆì§ˆ ê´€ë¦¬ì™€ ë§‰ integrityë¥¼ ìœ ì§€í•˜ëŠ” ê¸°ë³¸ ì„¸í¬ ê³¼ì •**ì„ ë‹¤ë£¹ë‹ˆë‹¤. Peptidoglycan homeostasis, ribosome ìƒë¬¼í•™, ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘, ë§‰ êµ¬ì„±ì˜ í›„ì„±ìœ ì „í•™ì  ì¡°ì ˆì„ í¬ê´„í•©ë‹ˆë‹¤.

### ì™œ ì´ ì„¸ì…˜ì´ ì¤‘ìš”í•œê°€?

- ğŸ”¬ **ê¸°ì´ˆ ë©”ì»¤ë‹ˆì¦˜**: ëª¨ë“  ì„¸í¬ ê³¼ì •ì˜ ê¸°ë°˜ì´ ë˜ëŠ” í•­ìƒì„±
- ğŸ¦  **í•­ìƒì œ íƒ€ê²Ÿ**: Cell wall, ribosome íƒ€ê²ŸíŒ… ë©”ì»¤ë‹ˆì¦˜ ì´í•´
- ğŸŒ **ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘**: ì„¸ê· ì˜ ìƒì¡´ ì „ëµ
- ğŸ’Š **ì‹ ê·œ íƒ€ê²Ÿ ë°œêµ´**: í’ˆì§ˆ ê´€ë¦¬ ì‹œìŠ¤í…œì„ í‘œì ìœ¼ë¡œ

---

## ğŸ“‹ ë°œí‘œë³„ ìƒì„¸ ë¶„ì„

### ğŸ”¹ ë°œí‘œ 1 (09:00-09:30)

**ì—°ì‚¬**: Hongbaek Cho (ì¡°í™ë°±)
**ì†Œì†**: Sungkyunkwan University (ì„±ê· ê´€ëŒ€í•™êµ)
**ì œëª©**: A periplasmic protein modulates the proteolysis of peptidoglycan hydrolases to maintain cell wall homeostasis in *Escherichia coli*

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ê°œë…**:
- Peptidoglycan (PG) hydrolase ì¡°ì ˆ
- ì„¸í¬ë²½ í•­ìƒì„± ë©”ì»¤ë‹ˆì¦˜
- Periplasmic quality control ì‹œìŠ¤í…œ

**ì™œ ì¤‘ìš”í•œê°€**:
- **í•­ìƒì œ ë‚´ì„± ì´í•´**: Î²-lactam í•­ìƒì œê°€ PG í•©ì„±ì„ íƒ€ê²ŸíŒ…
- **ì‹ ê·œ í•­ìƒì œ íƒ€ê²Ÿ**: Hydrolase ì¡°ì ˆ ë‹¨ë°±ì§ˆ
- **ì„¸í¬ë²½ ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ ê²½ë¡œ**

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Peptidoglycan (PG) êµ¬ì¡° ë° ê¸°ëŠ¥**

**PG ê¸°ë³¸ êµ¬ì¡°**:
```
â”Œâ”€ NAG â”€ NAM â”€ NAG â”€ NAM â”€â”
â”‚    |     |              â”‚
â”‚  Peptide bridge         â”‚
â”‚    |     |              â”‚
â””â”€ NAG â”€ NAM â”€ NAG â”€ NAM â”€â”˜
```

- **NAG**: N-acetylglucosamine
- **NAM**: N-acetylmuramic acid
- **Peptide bridge**: L-Ala, D-Glu, meso-DAP, D-Ala

**ê¸°ëŠ¥**:
- ì„¸í¬ í˜•íƒœ ìœ ì§€
- ì‚¼íˆ¬ì•• ì €í•­
- ì„¸í¬ ë¶„ì—´ ì‹œ ê²©ë²½ í˜•ì„±

**2. PG Hydrolases (ê°€ìˆ˜ë¶„í•´íš¨ì†Œ)**

**ì¢…ë¥˜**:
- **Autolysins**: PG ë¶„í•´ë¡œ ì„±ì¥ ë° ë¶„ì—´ ì§€ì›
- **Amidases**: Peptide-glycan ê²°í•© ì ˆë‹¨
- **Endopeptidases**: Peptide bridge ì ˆë‹¨
- **Glycosidases**: Sugar backbone ì ˆë‹¨

**ì–‘ë‚ ì˜ ê²€**:
- **í•„ìš”**: ì„¸í¬ ì„±ì¥, ë¶„ì—´, ì¬êµ¬ì„±
- **ìœ„í—˜**: ê³¼ë„í•œ í™œì„± â†’ ì„¸í¬ë²½ ì•½í™” â†’ Lysis

**3. Periplasmic Proteinì˜ ì¡°ì ˆ ì—­í• **

**ì˜ˆìƒ ë©”ì»¤ë‹ˆì¦˜**:
- **Protease inhibitor**: Hydrolaseë¥¼ ë¶„í•´í•˜ëŠ” protease ì–µì œ
- **Chaperone**: Hydrolase í™œì„± ì¡°ì ˆ
- **Scaffold**: Hydrolaseë¥¼ ì ì ˆí•œ ìœ„ì¹˜ë¡œ ìœ ë„

**Homeostasis ìœ ì§€**:
```
PG Synthesis (í•©ì„±)
      â†• (ê· í˜•)
PG Degradation (ë¶„í•´)
      â†“
Controlled by Periplasmic Protein
```

**4. í•­ìƒì œ ë‚´ì„±ê³¼ì˜ ì—°ê´€**

**Î²-lactam í•­ìƒì œ**:
- PG í•©ì„± ì–µì œ â†’ í•©ì„±/ë¶„í•´ ë¶ˆê· í˜•
- Hydrolase ê³„ì† ì‘ë™ â†’ ì„¸í¬ë²½ ì•½í™” â†’ Lysis

**ë‚´ì„± ë©”ì»¤ë‹ˆì¦˜**:
- Hydrolase í™œì„± ê°ì†Œ â†’ Î²-lactamì—ë„ lysis ì•ˆë¨
- Periplasmic protein ê³¼ë°œí˜„ â†’ Hydrolase ì¡°ì ˆ ê°•í™”

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**í•­ìƒì œ ê°œë°œ**:
- Periplasmic proteinì„ íƒ€ê²ŸíŒ… â†’ Î²-lactam ê°ìˆ˜ì„± íšŒë³µ
- Hydrolase ì¡°ì ˆ ê²½ë¡œ ì–µì œ â†’ ìƒˆë¡œìš´ í•­ìƒì œ ì‘ìš© ë©”ì»¤ë‹ˆì¦˜

**ê¸°ì´ˆ ì—°êµ¬**:
- ì„¸í¬ë²½ í•­ìƒì„± ë©”ì»¤ë‹ˆì¦˜ ì´í•´
- Periplasmic proteostasis network ê·œëª…

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Peptidoglycan êµ¬ì¡°**
- **Glycan strands**: NAG-NAM ë°˜ë³µ
- **Cross-linking**: Transpeptidaseê°€ peptide bridge í˜•ì„±
- **Thickness**: Gram-positive (20-80 nm) vs. Gram-negative (2-7 nm)

**2. Î²-lactam Antibiotics**
- **ë©”ì»¤ë‹ˆì¦˜**: Penicillin-binding proteins (PBPs) ì–µì œ â†’ PG í•©ì„± ì°¨ë‹¨
- **ì˜ˆì‹œ**: Penicillin, Ampicillin, Cephalosporins, Carbapenems
- **ë‚´ì„±**: Î²-lactamase (ë¶„í•´ íš¨ì†Œ), PBP ë³€ì´, efflux pumps

**3. Periplasm (ì£¼ë³€ì„¸í¬ì§ˆ)**
- **ìœ„ì¹˜**: Inner membraneì™€ outer membrane ì‚¬ì´ (Gram-negative)
- **í™˜ê²½**: Oxidizing (vs. reducing cytoplasm)
- **ê¸°ëŠ¥**: Protein folding, quality control, nutrient binding

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "ì´ **periplasmic proteinì˜ êµ¬ì¡°**ëŠ” ë°í˜€ì¡Œë‚˜ìš”? ì–´ë–¤ ë„ë©”ì¸ì„ ê°€ì§€ê³  ìˆë‚˜ìš”?"
2. "ë‹¤ë¥¸ ì„¸ê·  (Gram-positive, ë³‘ì›ì²´)ì—ë„ **ìœ ì‚¬í•œ ì‹œìŠ¤í…œ**ì´ ìˆë‚˜ìš”?"
3. "í•­ìƒì œ ë‚´ì„±ê· ì—ì„œ ì´ ë‹¨ë°±ì§ˆì˜ **ë°œí˜„ ìˆ˜ì¤€**ì´ ë³€í™”í•˜ë‚˜ìš”?"
4. "ì´ ë‹¨ë°±ì§ˆì„ **ì–µì œí•˜ëŠ” small molecule**ì„ ì°¾ì„ ìˆ˜ ìˆì„ê¹Œìš”?"

---

### ğŸ”¹ ë°œí‘œ 2 (09:30-10:00)

**ì—°ì‚¬**: Yoon-Mo Yang (ì–‘ìœ¤ëª¨)
**ì†Œì†**: Hanyang University (í•œì–‘ëŒ€í•™êµ)
**ì œëª©**: Ribosome remodeling and repair

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ê°œë…**:
- Ribosome quality control
- ì†ìƒëœ ribosome ìˆ˜ë¦¬ ë©”ì»¤ë‹ˆì¦˜
- Translation fidelity ìœ ì§€

**ì™œ ì¤‘ìš”í•œê°€**:
- **ëª¨ë“  ì„¸í¬ ê³¼ì •ì˜ ì¤‘ì‹¬**: Translation
- **í•­ìƒì œ ë©”ì»¤ë‹ˆì¦˜**: ë§ì€ í•­ìƒì œê°€ ribosome íƒ€ê²ŸíŒ…
- **ìŠ¤íŠ¸ë ˆìŠ¤ ìœ ë„ ribosome ë³€í˜• ì´í•´**

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Ribosome ì†ìƒì˜ ì›ì¸**

**ì†ìƒ ìœ í˜•**:
- **Oxidative damage**: ROSì— ì˜í•œ rRNA ì†ìƒ
- **Incorrect assembly**: Ribosomal proteins ì˜ëª» ê²°í•©
- **Collision**: ë²ˆì—­ ì¤‘ ribosome ì¶©ëŒ (stalled translation)
- **Antibiotic damage**: Aminoglycosides ë“±ì— ì˜í•œ êµ¬ì¡° ë³€í™”

**2. Ribosome Remodeling (ì¬êµ¬ì„±)**

**ì •ì˜**: Ribosome êµ¬ì¡°ë¥¼ ë³€ê²½í•˜ì—¬ ê¸°ëŠ¥ íšŒë³µ ë˜ëŠ” ì ì‘

**ë©”ì»¤ë‹ˆì¦˜ (ì˜ˆìƒ)**:
- **Protein exchange**: ì†ìƒëœ ribosomal protein êµì²´
- **rRNA modification**: Methylation, pseudouridylation
- **Assembly factors**: Specialized chaperones

**3. Ribosome Repair Pathways**

**Ribosome-associated Quality Control (RQC)**:
```
Stalled Ribosome
      â†“
Recognition (Hel2, PELO-Hbs1)
      â†“
Nascent Chain Degradation (Ltn1/Listerin)
      â†“
Ribosome Splitting
      â†“
40S Rescue (ABCE1)
60S Recycling
```

**ì„¸ê· ì˜ ribosome rescue**:
- **tmRNA/SmpB**: Stalled ribosome êµ¬ì¡°, ë¶ˆì™„ì „ ë‹¨ë°±ì§ˆì— tag ë¶€ì°© â†’ ë¶„í•´
- **ArfA/ArfB**: Alternative rescue factors
- **Ribosome recycling**: RRF + EF-G

**4. Translation Fidelity ìœ ì§€**

**Proofreading ë©”ì»¤ë‹ˆì¦˜**:
- **Initial selection**: aa-tRNA ì„ íƒ ì‹œ ì •í™•ë„ ê²€ì¦
- **Proofreading**: GTP hydrolysis í›„ ì¬ê²€ì¦
- **Error rate**: 10^-4 (1/10,000)

**Damaged ribosomeì˜ ì˜í–¥**:
- Fidelity ê°ì†Œ â†’ Mistranslation
- Growth defect
- Stress sensitivity

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**í•­ìƒì œ ì—°êµ¬**:
- Ribosome-targeting antibioticsì˜ ì‘ìš© ì´í•´
- Repair ë©”ì»¤ë‹ˆì¦˜ ì–µì œ â†’ í•­ìƒì œ íš¨ê³¼ ì¦ëŒ€

**ê¸°ì´ˆ ì—°êµ¬**:
- Ribosome í’ˆì§ˆ ê´€ë¦¬ì˜ ë¶„ì ë©”ì»¤ë‹ˆì¦˜
- Stress adaptationì—ì„œ ribosomeì˜ ì—­í• 

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Ribosome êµ¬ì¡°**
- **ì„¸ê·  (70S)**: 30S (small) + 50S (large)
  - **30S**: 16S rRNA + 21 proteins
  - **50S**: 23S + 5S rRNA + 31 proteins
- **ê¸°ëŠ¥**:
  - **30S**: mRNA binding, codon recognition
  - **50S**: Peptide bond formation (peptidyl transferase center)

**2. Ribosome-targeting Antibiotics**
- **30S inhibitors**: Tetracycline, aminoglycosides (mistranslation ìœ ë„)
- **50S inhibitors**: Chloramphenicol, macrolides (peptide bond í˜•ì„± ì–µì œ)

**3. Cryo-EM in Ribosome Research**
- **í•´ìƒë„**: ~2-3 Ã…
- **ìš©ë„**: Ribosome êµ¬ì¡° ë³€í™” ê´€ì°°, í•­ìƒì œ ê²°í•© ë¶€ìœ„

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "ì–´ë–¤ **ìœ í˜•ì˜ ì†ìƒ**ì´ ê°€ì¥ í”í•œê°€ìš”? ìƒë¦¬ì  ì¡°ê±´ì—ì„œ?"
2. "Ribosome repairê°€ **ì–¼ë§ˆë‚˜ ë¹ ë¥´ê²Œ** ì¼ì–´ë‚˜ë‚˜ìš”? Minutes? Hours?"
3. "í•­ìƒì œ ë…¸ì¶œ í›„ ribosome remodelingì´ **ë‚´ì„± ë°œë‹¬**ì— ê¸°ì—¬í•˜ë‚˜ìš”?"
4. "**Cryo-EMìœ¼ë¡œ ribosome repair ì¤‘ê°„ ë‹¨ê³„**ë¥¼ ê´€ì°°í•  ìˆ˜ ìˆë‚˜ìš”?"

---

### ğŸ”¹ ë°œí‘œ 3 (10:00-10:30)

**ì—°ì‚¬**: Young-Jun Choe (ìµœì˜ì¤€)
**ì†Œì†**: Nanyang Technological University, Singapore
**ì œëª©**: Starvation and mRNA Damage: Different stresses converging on the ribosome

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ê°œë…**:
- ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ì´ translationì— ìˆ˜ë ´
- mRNA quality control
- Ribosomeì´ ìŠ¤íŠ¸ë ˆìŠ¤ ì„¼ì„œ ì—­í• 

**ì™œ ì¤‘ìš”í•œê°€**:
- **ì„¸ê·  persistence ë° dormancy** ì´í•´
- **VBNC (Viable But Non-Culturable) state** ë©”ì»¤ë‹ˆì¦˜
- **ìŠ¤íŠ¸ë ˆìŠ¤ ìƒì¡´ ì „ëµ**

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. ë‹¤ì–‘í•œ ìŠ¤íŠ¸ë ˆìŠ¤ì˜ ê³µí†µì : Ribosome**

**ìŠ¤íŠ¸ë ˆìŠ¤ ìœ í˜•**:
- **Starvation** (ì˜ì–‘ ê²°í•): Amino acid, carbon source
- **mRNA damage**: ROS, UV, chemical
- **Oxidative stress**: Protein/RNA ì‚°í™”
- **Antibiotic stress**: Translation ì–µì œ

**ì™œ Ribosomeì— ìˆ˜ë ´?**
- Translation = ì—ë„ˆì§€ ì†Œë¹„ ìµœëŒ€ ê³¼ì • (70-80%)
- ëª¨ë“  ìŠ¤íŠ¸ë ˆìŠ¤ â†’ Translation ê°ì†Œ â†’ ì—ë„ˆì§€ ì ˆì•½
- Ribosome = ì„¸í¬ ìƒíƒœì˜ barometer

**2. Starvation Response**

**Stringent Response** (ì—„ê²© ë°˜ì‘):
```
Amino acid starvation
      â†“
Uncharged tRNA accumulation
      â†“
RelA activation (on ribosome)
      â†“
(p)ppGpp synthesis
      â†“
Transcription reprogramming
 â”œâ”€ Biosynthesis â†“
 â”œâ”€ Translation â†“
 â””â”€ Stress genes â†‘
```

**(p)ppGpp (Magic spot)**:
- Global regulator
- RNA polymerase ì–µì œ â†’ rRNA/tRNA í•©ì„± ê°ì†Œ
- Ribosome ìˆ˜ ê°ì†Œ â†’ Translation capacity ì¡°ì ˆ

**3. mRNA Damage Response**

**mRNA ì†ìƒ ìœ í˜•**:
- **Oxidative damage**: 8-oxoguanosine
- **Fragmentation**: Endonuclease ì ˆë‹¨
- **Depurination**: Acidic pH

**Ribosomeì˜ ì—­í• **:
- **Collision detection**: Ribosomeì´ ì†ìƒ mRNAì—ì„œ ë©ˆì¶¤ â†’ ì¶©ëŒ
- **Rescue activation**: tmRNA/SmpB, ArfA í™œì„±í™”
- **mRNA decay**: Endonuclease ëª¨ì§‘ â†’ ì†ìƒ mRNA ë¶„í•´

**4. Convergence on Ribosome**

**ê³µí†µ ê²½ë¡œ**:
```
Different Stresses
 â”œâ”€ Starvation
 â”œâ”€ Oxidative
 â”œâ”€ mRNA damage
 â””â”€ Antibiotic
      â†“
Translation Arrest
      â†“
Ribosome-associated Signaling
 â”œâ”€ (p)ppGpp
 â”œâ”€ RQC pathways
 â””â”€ mRNA decay
      â†“
Stress Adaptation
```

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**VBNC State ì—°êµ¬**:
- Ribosomeì´ dormancy ì§„ì…ì˜ key regulator
- Translation arrest = VBNCì˜ íŠ¹ì§•
- Resuscitation ì‹œ ribosome reactivation

**Persistence ì—°êµ¬**:
- Persister cells = non-growing but alive
- Translation reductionì´ í•µì‹¬
- í•­ìƒì œ tolerance ë©”ì»¤ë‹ˆì¦˜

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Stringent Response**
- **RelA**: Ribosome-associated (p)ppGpp synthetase
- **SpoT**: Bifunctional (synthetase + hydrolase)
- **Target**: RNA polymerase (RNAP)
  - rRNA/tRNA promoter ì–µì œ
  - Amino acid biosynthesis gene í™œì„±í™”

**2. VBNC (Viable But Non-Culturable)**
- **ì •ì˜**: ì‚´ì•„ìˆì§€ë§Œ í‘œì¤€ ë°°ì§€ì—ì„œ ë°°ì–‘ ì•ˆë¨
- **ì›ì¸**: Stress (starvation, cold, oxidation)
- **íŠ¹ì§•**: Metabolic activity â†“, ribosome ìˆ˜ â†“
- **Resuscitation**: ì ì ˆí•œ ì¡°ê±´ íšŒë³µ â†’ ì„±ì¥ ì¬ê°œ

**3. Persister Cells**
- **ì •ì˜**: ì¼ì‹œì ìœ¼ë¡œ í•­ìƒì œ ë‚´ì„± (dormant)
- **ë¹„ìœ¨**: 0.01-1% of population
- **ë©”ì»¤ë‹ˆì¦˜**: Translation arrest, toxin-antitoxin systems
- **ì„ìƒ ì¤‘ìš”ì„±**: ë§Œì„± ê°ì—¼, ì¬ë°œ

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "Starvationê³¼ mRNA damageê°€ **ê°™ì€ ribosome-associated factor**ë¥¼ í™œì„±í™”í•˜ë‚˜ìš”?"
2. "VBNC ì„¸í¬ì˜ ribosomeì€ **êµ¬ì¡°ì ìœ¼ë¡œ ë³€í™”**í•˜ë‚˜ìš”? Hibernating ribosomes?"
3. "ì´ ìŠ¤íŠ¸ë ˆìŠ¤ convergenceë¥¼ **í•­ìƒì œ íš¨ê³¼ ì¦ëŒ€**ì— í™œìš©í•  ìˆ˜ ìˆë‚˜ìš”?"
4. "**Metatranscriptomics**ë¡œ í™˜ê²½ ìƒ˜í”Œì˜ ribosome stressë¥¼ ëª¨ë‹ˆí„°ë§ ê°€ëŠ¥í•œê°€ìš”?"

---

### ğŸ”¹ ë°œí‘œ 4 (10:30-10:50)

**ì—°ì‚¬**: Shinae Park (ë°•ì‹ ì• )
**ì†Œì†**: Kangwon National University (ê°•ì›ëŒ€í•™êµ)
**ì œëª©**: Epigenetic control of membrane homeostasis via Set1-dependent H3K4 methylation

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ê°œë…**:
- ì§„ê· /ì§„í•µ ë¯¸ìƒë¬¼ì˜ histone methylation
- ë§‰ ì§€ì§ˆ êµ¬ì„±ì˜ í›„ì„±ìœ ì „í•™ì  ì¡°ì ˆ
- Set1/COMPASS complex ê¸°ëŠ¥

**ì™œ ì¤‘ìš”í•œê°€**:
- **ì§„ê·  ë³‘ì›ì²´ ìƒë¬¼í•™**: ë§‰ êµ¬ì„±ì´ ì•½ë¬¼ ë‚´ì„±ì— ì˜í–¥
- **ìŠ¤íŠ¸ë ˆìŠ¤ ì ì‘ ë©”ì»¤ë‹ˆì¦˜**
- **í›„ì„±ìœ ì „í•™ì  ì•½ë¬¼ íƒ€ê²Ÿ**

**âš ï¸ Note**: ì´ ë°œí‘œëŠ” **ì§„í•µ ë¯¸ìƒë¬¼ (ì§„ê· /íš¨ëª¨)** ì¤‘ì‹¬, ì„¸ê·  ì•„ë‹˜

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Histone Methylation in Fungi**

**H3K4 Methylation**:
- **ìœ„ì¹˜**: Histone H3, Lysine 4
- **íš¨ì†Œ**: Set1 (methyltransferase) in COMPASS complex
- **ê¸°ëŠ¥**: ì¼ë°˜ì ìœ¼ë¡œ í™œì„± ì „ì‚¬ì™€ ì—°ê´€

**COMPASS Complex**:
- Set1 (catalytic subunit)
- Scaffold proteins (Bre2, Sdc1, Spp1, Swd1, Swd2, Swd3)

**2. Membrane Lipid Composition**

**ì§„ê·  ë§‰ ì§€ì§ˆ**:
- **Phospholipids**: PC, PE, PI, PS
- **Ergosterol**: ì§„ê· ì˜ sterol (ì½œë ˆìŠ¤í…Œë¡¤ê³¼ ìœ ì‚¬)
- **Sphingolipids**: Ceramides, complex sphingolipids

**í™˜ê²½ ì ì‘**:
- ì˜¨ë„ ë³€í™” â†’ ì§€ë°©ì‚° í¬í™”ë„ ì¡°ì ˆ
- ìŠ¤íŠ¸ë ˆìŠ¤ â†’ Ergosterol í•¨ëŸ‰ ë³€í™”
- í•­ì§„ê· ì œ â†’ ë§‰ êµ¬ì„± ë¦¬ëª¨ë¸ë§

**3. Set1-dependent Regulation**

**ì˜ˆìƒ ë©”ì»¤ë‹ˆì¦˜**:
```
Stress Signal
      â†“
Set1/COMPASS activation
      â†“
H3K4me3 at lipid biosynthesis genes
      â†“
Transcription â†‘
 â”œâ”€ ERG genes (ergosterol)
 â”œâ”€ FA synthesis genes
 â””â”€ Phospholipid genes
      â†“
Membrane composition change
      â†“
Stress adaptation / Drug resistance
```

**4. í•­ì§„ê· ì œ ë‚´ì„±ê³¼ì˜ ì—°ê´€**

**Azole í•­ì§„ê· ì œ**:
- **íƒ€ê²Ÿ**: Ergosterol biosynthesis (Erg11)
- **ë‚´ì„±**: ERG gene ê³¼ë°œí˜„, efflux pumps

**Set1ì˜ ì—­í• **:
- ERG gene lociì˜ H3K4me3 ì¦ê°€
- Azole ë…¸ì¶œ ì‹œ ERG ë°œí˜„ ë¹ ë¥´ê²Œ ì¦ê°€
- Set1 deletion â†’ Azole sensitivity

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ì§„ê·  ë³‘ì›ì²´ ì—°êµ¬**:
- Set1 ì–µì œ â†’ í•­ì§„ê· ì œ ê°ìˆ˜ì„± ì¦ê°€
- Epigenetic drug targets

**ê¸°ì´ˆ ì—°êµ¬**:
- Chromatin regulation of metabolism
- Stress-induced epigenetic changes

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Histone Methylation**
- **Writers**: Methyltransferases (e.g., Set1)
- **Erasers**: Demethylases (e.g., Jhd2)
- **Readers**: Proteins recognizing methylated histones
- **States**: me1, me2, me3 (mono-, di-, tri-methylation)

**2. Ergosterol vs. Cholesterol**
- **ì§„ê· **: Ergosterol
- **í¬ìœ ë¥˜**: Cholesterol
- **ì°¨ì´ì **: í•­ì§„ê· ì œ ì„ íƒì  ë…ì„±ì˜ ê¸°ë°˜

**3. Azole Antifungals**
- **ë©”ì»¤ë‹ˆì¦˜**: Erg11 (lanosterol 14Î±-demethylase) ì–µì œ
- **ì˜ˆì‹œ**: Fluconazole, Voriconazole, Itraconazole
- **ë‚´ì„±**: ERG11 mutations, overexpression, efflux pumps

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "Set1 deletionì´ **ë‹¤ë¥¸ ìŠ¤íŠ¸ë ˆìŠ¤ (oxidative, heat)**ì—ë„ ì˜í–¥ì„ ì£¼ë‚˜ìš”?"
2. "ë³‘ì›ì„± ì§„ê·  (C. albicans, A. fumigatus)ì—ì„œë„ **ë™ì¼í•œ ë©”ì»¤ë‹ˆì¦˜**ì¸ê°€ìš”?"
3. "**Histone methyltransferase inhibitors**ê°€ í•­ì§„ê· ì œ adjuvantë¡œ ê°€ëŠ¥í•œê°€ìš”?"
4. "H3K4me3 ChIP-seqìœ¼ë¡œ **genome-wide target genes**ë¥¼ í™•ì¸í–ˆë‚˜ìš”?"

---

## ğŸ§  ì„¸ì…˜ ì „ì²´ í•µì‹¬ ê°œë… ì •ë¦¬

### í•„ìˆ˜ ì•”ê¸° ì‚¬í•­

**1. Homeostasis ìœ ì§€ ë©”ì»¤ë‹ˆì¦˜**

| ì‹œìŠ¤í…œ | í•µì‹¬ ì¡°ì ˆì | ê¸°ëŠ¥ |
|--------|-------------|------|
| **Cell Wall** | Periplasmic protein | PG hydrolase ì¡°ì ˆ |
| **Ribosome** | RQC, tmRNA/SmpB | ì†ìƒ ribosome ìˆ˜ë¦¬/êµ¬ì¡° |
| **Translation** | (p)ppGpp, stringent response | ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ í†µí•© |
| **Membrane (ì§„ê· )** | Set1/H3K4me3 | ì§€ì§ˆ ìƒí•©ì„± ìœ ì „ì ì¡°ì ˆ |

**2. ìŠ¤íŠ¸ë ˆìŠ¤ ìˆ˜ë ´ (Convergence)**

```
Multiple Stresses
 â”œâ”€ Starvation â†’ (p)ppGpp
 â”œâ”€ Oxidative â†’ mRNA damage
 â”œâ”€ mRNA damage â†’ Ribosome stalling
 â””â”€ Antibiotic â†’ Translation arrest
      â†“
Common Response: Translation Control
      â†“
Survival / Persistence
```

**3. í•­ìƒì œ ì—°ê´€**

- **Cell wall antibiotics**: PG homeostasis êµë€
- **Ribosome antibiotics**: Translation ì–µì œ, ribosome ì†ìƒ
- **ë‚´ì„± ë©”ì»¤ë‹ˆì¦˜**: Homeostasis system ê°•í™”

---

## ğŸ“š ì‚¬ì „ ì½ê¸° ìë£Œ

### í•„ìˆ˜ (Must Read)

1. **"Ribosome Quality Control"** (2023, Annual Review of Microbiology)
   - RQC ë©”ì»¤ë‹ˆì¦˜ ì „ë°˜

2. **"Stringent Response"** (2022, Nature Reviews Microbiology)
   - (p)ppGppì˜ ì—­í• 

### ì¶”ì²œ (Recommended)

3. **"Peptidoglycan Hydrolases"** (2021)
   - ì„¸í¬ë²½ ë¦¬ëª¨ë¸ë§

4. **"Epigenetic Regulation in Fungi"** (2024)
   - ì§„ê· ì˜ chromatin ì¡°ì ˆ

---

## ğŸ¤ ì¤€ë¹„í•  ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸

### Top Questions

1. **[Cho]** "Periplasmic proteinì„ íƒ€ê²ŸíŒ…í•˜ëŠ” **small molecule inhibitor** ìŠ¤í¬ë¦¬ë‹ ê²°ê³¼ëŠ”?"
2. **[Yang]** "Ribosome repairê°€ **í•­ìƒì œ ë‚´ì„± ë°œë‹¬**ì— ê¸°ì—¬í•˜ë‚˜ìš”? Evolutionary perspective?"
3. **[Choe]** "VBNC ìƒíƒœì˜ ribosomeì„ **reactivate**í•˜ëŠ” ì‹ í˜¸ëŠ” ë¬´ì—‡ì¸ê°€ìš”?"
4. **[Park]** "Set1 inhibitor + azole **combination therapy**ì˜ ì‹œë„ˆì§€ëŠ”?"

---

## ğŸ¤ ë„¤íŠ¸ì›Œí‚¹ ì „ëµ

### ìš°ì„ ìˆœìœ„ ì—°ì‚¬

**1. Hongbaek Cho (ì¡°í™ë°±)** - ì„±ê· ê´€ëŒ€
- ì„¸í¬ë²½ ìƒë¬¼í•™
- í•­ìƒì œ íƒ€ê²Ÿ ë°œêµ´
- í•œêµ­ ì—°êµ¬ì â†’ í˜‘ë ¥ ìš©ì´

**2. Yoon-Mo Yang (ì–‘ìœ¤ëª¨)** - í•œì–‘ëŒ€
- Ribosome êµ¬ì¡° ìƒë¬¼í•™
- Cryo-EM ì „ë¬¸ê°€
- êµ­ë‚´ ìµœê³  ìˆ˜ì¤€

**3. Shinae Park (ë°•ì‹ ì• )** - ê°•ì›ëŒ€ (G-LAMP)
- ì§„ê·  í›„ì„±ìœ ì „í•™
- ì§€ì—­ ê±°ì  ì„¼í„°
- í˜‘ë ¥ ê¸°íšŒ

---

## âš¡ ì„¸ì…˜ ë‹¹ì¼ ì²´í¬ë¦¬ìŠ¤íŠ¸

### ì‚¬ì „ ì¤€ë¹„
- [ ] PG êµ¬ì¡°, ribosome êµ¬ì¡° ë³µìŠµ
- [ ] Stringent response ê°œë… ìˆ™ì§€
- [ ] ì—°ì‚¬ ìµœê·¼ ë…¼ë¬¸ í™•ì¸
- [ ] ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸ ì •ë¦¬

### ì„¸ì…˜ ì¤‘
- [ ] í•µì‹¬ ë©”ì»¤ë‹ˆì¦˜ ë‹¤ì´ì–´ê·¸ë¨ ìŠ¤ì¼€ì¹˜
- [ ] ì‹ ê·œ ë‹¨ë°±ì§ˆ/ê²½ë¡œ ë©”ëª¨
- [ ] ë°©ë²•ë¡  (Cryo-EM, ChIP-seq ë“±) ê¸°ë¡

### ì„¸ì…˜ í›„
- [ ] ì—°ì‚¬ì™€ ì§ˆì˜ì‘ë‹µ
- [ ] ëª…í•¨ êµí™˜
- [ ] Follow-up ì—°êµ¬ ì•„ì´ë””ì–´ ì •ë¦¬

---

## ğŸ”— ë‹¤ë¥¸ ì„¸ì…˜ê³¼ì˜ ì—°ê²°

**S4 (Respiratory Pathogens)ì™€ ì—°ê³„**:
- S3ì˜ ê¸°ì´ˆ ë©”ì»¤ë‹ˆì¦˜ â†’ S4ì˜ í•­ìƒì œ íƒ€ê²Ÿ ì‘ìš©
- Ribosome/cell wall homeostasis â†’ ë³‘ì›ì²´ ìƒì¡´ ì „ëµ

**S13 (Macromolecular Systems)ê³¼ ì—°ê³„**:
- ë‘˜ ë‹¤ êµ¬ì¡° ìƒë¬¼í•™ ì¤‘ì‹¬
- Proteases, ribosomes ê³µí†µ ì£¼ì œ

**S5 (Fungal Pathogenesis)ì™€ ì—°ê³„**:
- S3 ë°œí‘œ 4 (ì§„ê·  í›„ì„±ìœ ì „í•™) â†’ S5 (ì§„ê·  ë³‘ì›ì„±)

---

**ì´ ì„¸ì…˜ í›„ ë‹¹ì‹ ì€**:
âœ… Cellular homeostasis ê¸°ë³¸ ë©”ì»¤ë‹ˆì¦˜ ì´í•´
âœ… Ribosome quality control ê²½ë¡œ íŒŒì•…
âœ… ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ì˜ í†µí•©ì  ì´í•´
âœ… í•­ìƒì œ ì‘ìš© ë©”ì»¤ë‹ˆì¦˜ì˜ ê¸°ì´ˆ ì§€ì‹ í™•ë³´
